My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Underrepresentation of women in new drug trials.

    Kinney EL, Trautmann J, Gold JA, Vesell ES, Zelis R.

    Ann Intern Med. 1981 Oct;95(4):495-9.PMID: 7283301 [PubMed - indexed for MEDLINE]Related articles

    2.

    Underrepresentation of women in clinical drug trials.

    Schmucker DL, Vesell ES.

    Clin Pharmacol Ther. 1993 Jul;54(1):11-5. No abstract available. PMID: 8330458 [PubMed - indexed for MEDLINE]Related articles

    3.

    Current issues surrounding women and minorities in drug trials.

    Wermeling DP, Selwitz AS.

    Ann Pharmacother. 1993 Jul-Aug;27(7-8):904-11.PMID: 8364277 [PubMed - indexed for MEDLINE]Related articles

    4.

    Don't test, do sell: legal implications of inclusion and exclusion of women in clinical drug trials.

    Herz SE.

    Epilepsia. 1997;38 Suppl 4:S42-9. Review.PMID: 9240240 [PubMed - indexed for MEDLINE]Related articles

    5.

    Conference report: complex clinical, legal, and ethical issues of pregnant and postpartum women as subjects in clinical trials.

    Goodrum LA, Hankins GD, Jermain D, Chanaud CM.

    J Womens Health (Larchmt). 2003 Nov;12(9):857-67. Review.PMID: 14670165 [PubMed - indexed for MEDLINE]Related articles

    6.

    Studying women in clinical trials: scientific and legal implications.

    Weisman SM, Schwartz D.

    Gend Med. 2007 Mar;4(1):3-7.PMID: 17584621 [PubMed - indexed for MEDLINE]Related articles

    7.

    Postmarketing evaluations help determine contraceptive safety, efficacy.

    [No authors listed]

    Network. 1988 Winter;9(2):1-2, 7.PMID: 12280950 [PubMed - indexed for MEDLINE]Related articles

    8.

    Trials in women.

    Battino D.

    Epilepsy Res. 2001 May;45(1-3):141-5; discussion 147. Review.PMID: 11461817 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.

    Ding EL, Powe NR, Manson JE, Sherber NS, Braunstein JB.

    Arch Intern Med. 2007 May 14;167(9):905-12.PMID: 17502531 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.

    Merkatz RB, Temple R, Subel S, Feiden K, Kessler DA.

    N Engl J Med. 1993 Jul 22;329(4):292-6. No abstract available. PMID: 8305004 [PubMed - indexed for MEDLINE]Related articles

    11.

    Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

    Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS.

    N Engl J Med. 1999 Dec 30;341(27):2061-7.PMID: 10615079 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The industry perspective on the inclusion of women in clinical trials.

    Bush JK.

    Acad Med. 1994 Sep;69(9):708-15.PMID: 8074760 [PubMed - indexed for MEDLINE]Related articles

    13.

    Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.

    Malik M, Camm AJ.

    Drug Saf. 2001;24(5):323-51. Review.PMID: 11419561 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical drug evaluation: the regulatory perspectives.

    Ng TL.

    Ann Acad Med Singapore. 2000 Sep;29(5):616-20.PMID: 11126697 [PubMed - indexed for MEDLINE]Related articles

    15.

    Age discrimination in trials and treatment: old dogs and new tricks.

    Godlovitch G.

    Monash Bioeth Rev. 2003 Jul;22(3):66-77.PMID: 14682321 [PubMed - indexed for MEDLINE]Related articles

    16.

    Ethical issues in the development of new agents.

    Daugherty CK.

    Invest New Drugs. 1999;17(2):145-53. Review.PMID: 10638485 [PubMed - indexed for MEDLINE]Related articles

    17.

    Females in clinical studies: where are we going?

    Uhl K, Parekh A, Kweder S.

    Clin Pharmacol Ther. 2007 Apr;81(4):600-2. Epub 2007 Feb 21.PMID: 17314925 [PubMed - indexed for MEDLINE]Related articles

    18.

    The evaluation of pharmacologic therapy in humans: a brief summary of the drug evaluation process and guidelines for clinical trials as they related to women.

    Schwartz JB.

    J Gend Specif Med. 2001;4(4):13-7. Review.PMID: 11727466 [PubMed - indexed for MEDLINE]Related articles

    19.

    Inclusion of women in clinical trials: a historical overview of scientific, ethical, and legal issues.

    Merkatz RB.

    J Obstet Gynecol Neonatal Nurs. 1998 Jan-Feb;27(1):78-84. Review.PMID: 9475131 [PubMed - indexed for MEDLINE]Related articles

    20.

    The causes and effects of socio-demographic exclusions from clinical trials.

    Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

    Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.PMID: 16181564 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity